Clinical Trial Update: PK & Tolerability of CNV1014802 in Young and Elderly Healthy Volunteers [Phase 1]

View source ↗

Summary

Biogen conducted a Phase 1 pharmacokinetics and tolerability study of CNV1014802 in young and elderly healthy volunteers. Trigeminal neuralgia is listed as the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Trigeminal Neuralgia

Drugs mentioned

• CNV1014802

Snippet

Sponsor: Biogen | Conditions: Trigeminal Neuralgia | Phase 1 | Status: COMPLETED